Standardization and quality assurance for antimicrobial resistance surveillance of Streptococcus pneumoniae and Staphylococcus aureus within the European.

Slides:

Advertisements

Similar presentations

Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages

Advertisements

Laboratory diagnosis and biosafety issues of biological warfare agents

Standardization and quality assurance for antimicrobial resistance surveillance of Streptococcus pneumoniae and Staphylococcus aureus within the European.

G. Cornaglia, A. Lönnroth, M. Struelens

Approach to diagnosis of infective endocarditis

Molecular characterization of methicillin-resistant Staphylococcus aureus isolated over a 2-year period in a Qatari hospital from multinational patients

Antimicrobial resistance in viridans group streptococci among patients with and without the diagnosis of cancer in the USA, Canada and Latin America

P. Clarke, S. Murchan, E.G. Smyth, H. Humphreys

Correlation between the activity of different fluoroquinolones and the presence of mechanisms of quinolone resistance in epidemiologically related and.

Control of multidrug-resistant Gram-negative bacteria in low- and middle-income countries—high impact interventions without much resources N. Singh,

European perspective and update on the management of nosocomial pneumonia due to methicillin-resistant Staphylococcus aureus after more than 10 years.

Herpes zoster in non-hospitalized children

Antimicrobial Activity of SCH 27899, Oligosaccharide Member of the Everninomycin Class with a Wide Gram-Positive Spectrum Ronald N. Jones, M.D., Mary.

In-vitro susceptibility and molecular characterisation of macrolide resistance mechanisms among Streptococcus pneumonia isolates in The Netherlands: the.

In vitro activity of cefpirome and vancomycin in combination against gentamicin- susceptible and gentamicin-resistant Staphylococcus aureus A. Carricajo,

Clinical impact of antibiotic-resistant Gram-positive pathogens

Cost-effectiveness of universal MRSA screening on admission to surgery

R. Cantón Clinical Microbiology and Infection

Antimicrobial drug use and infection control practices associated with the prevalence of methicillin-resistant Staphylococcus aureus in European hospitals

How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development R. Bax Clinical Microbiology.

Antimicrobial susceptibility of Streptococcus pneumoniae in Latin America: results from five years of the SENTRY Antimicrobial Surveillance Program M.

Use of surveillance cultures and enteral vancomycin to control methicillin-resistant Staphylococcus aureus in a paediatric intensive care unit K. Thorburn,

W. Witte, B. Pasemann, C. Cuny Clinical Microbiology and Infection

How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach D. Guillemot Clinical Microbiology.

D.E. Low Clinical Microbiology and Infection

Vector control: a cornerstone in the malaria elimination campaign

Pharmacodynamics of doxycycline

Do we need new antibiotics?

C-3′Quaternary Ammonium Cephems, a New Wave of Cephalosporins

Training for the infectious diseases speciality in Norway

Pharmacodynamic properties of HMR 3004, a novel ketolide, on respiratory pathogens, enterococci and Bacteroides fragilis demonstrated by studies of time.

Low prevalence of methicillin-resistant Staphylococcus aureus with reduced susceptibility to glycopeptides in Belgian hospitals C. Nonhoff, O. Denis,

D. Esel, B. Sümerkan, S. Kocagöz Clinical Microbiology and Infection

Laboratory diagnosis and biosafety issues of biological warfare agents

Bacterial resistance—the clinical challenge

In vitro selection of antibiotic resistance in Pseudomonas aeruginosa

Transmissibility of livestock-associated methicillin-resistant Staphylococcus aureus (ST398) in Dutch hospitals M.W.M. Wassenberg, M.C.J. Bootsma, A.

Detection of specific IgM antibody in the investigation of an outbreak of pneumonia due to Legionella pneumophila serogroup 1 F. de Ory, J.M. Echevarría,

Isolation rate, T-serotyping and susceptibility to antibiotics of Group A Streptococcus from pediatric infections in Athens* M. Kanellopoulou, A. Makri,

M. Aires-de-Sousa Clinical Microbiology and Infection

Effect of antioxidants on the immune response of Helicobacter pylori

Laboratory diagnosis of Clostridium difficile disease

T.M. File Clinical Microbiology and Infection

Epidemiology of penicillin resistance in Streptococcus pneumoniae isolates in eastern France Daniel Talon, Blandine Mulin, Marie-Jeanne Dupont, Anne-Marie.

Y. Tveten, A. Jenkins, A.G. Allum, B.-E. Kristiansen

Harmonised monitoring of antimicrobial resistance in Salmonella and Campylobacter isolates from food animals in the European Union S. Bronzwaer Clinical.

Community-acquired pneumonia: epidemiologic and clinical consideration

P.M. Hawkey Clinical Microbiology and Infection

Circulation of international clones of levofloxacin non-susceptible Streptococcus pneumoniae in Taiwan Y.-C. Hsieh, L.-Y. Chang, Y.-C. Huang, H.-C. Lin,

Sequential time to positivity of blood cultures can be a predictor of prognosis of patients with persistent Staphylococcus aureus bacteraemia M.-S. Hsu,

G.M. Rossolini, E. Mantengoli Clinical Microbiology and Infection

Statin use and clinical outcomes among pneumonia patients

Clinical Microbiology and Infection

Clinical Microbiology and Infection

Active surveillance of antibiotic resistance prevalence in urinary tract and skin infections in the outpatient setting A. Kronenberg, S. Koenig, S. Droz,

Panton–Valentine leukocidin-encoding bacteriophage and gene sequence variation in community-associated methicillin-resistant Staphylococcus aureus J.A.

The atypical pneumonias: clinical diagnosis and importance

Facilitating learning and change in physicians: Implications for a system of continuing medical education in Europe Robert D. Fox Clinical Microbiology.

Abstracts Clinical Microbiology and Infection

New oral cephalosporins in pediatric community-acquired infections

J. Wilson, S. Elgohari, D. M. Livermore, B. Cookson, A. Johnson, T

A. Manzur, F. Gudiol Clinical Microbiology and Infection

O. Megged, A.M. Yinnon, D. Raveh, B. Rudensky, Y. Schlesinger

B.A. Cunha Clinical Microbiology and Infection

Susceptibility of multi-drug-resistant Pseudomonas aeruginosa in intensive care units: results from the European MYSTIC study group† H. Goossens Clinical.

J.L. Balcázar Clinical Microbiology and Infection

G.C. Schito Clinical Microbiology and Infection

D.A. Robinson, M.C. Enright Clinical Microbiology and Infection

Bactericidal activity and synergy studies of BAL9141, a novel pyrrolidinone-3- ylidenemethyl cephem, tested against streptococci, enterococci and methicillin-resistant.

The future of diagnostic bacteriology

Presentation transcript:

Standardization and quality assurance for antimicrobial resistance surveillance of Streptococcus pneumoniae and Staphylococcus aureus within the European Antimicrobial Resistance Surveillance System (EARSS)† W. Goettsch, S.L.A.M. Bronzwaer, A.J. de Neelin, M.C.J. Wale, H. Aubry-Damon, B. Olsson-Liljequist, M.J.W. Sprenger, J.E. Degener Clinical Microbiology and Infection Volume 6, Issue 2, Pages 59-63 (February 2000) DOI: 10.1046/j.1469-0691.2000.00027.x Copyright © 2000 European Society of Clinical Infectious Diseases Terms and Conditions

Figure 1 Structure of the European Antimicrobial Resistance Surveillance System. Clinical Microbiology and Infection 2000 6, 59-63DOI: (10.1046/j.1469-0691.2000.00027.x) Copyright © 2000 European Society of Clinical Infectious Diseases Terms and Conditions

Figure 2 Protocol for testing susceptibility of Staphylococcus aureus. Clinical Microbiology and Infection 2000 6, 59-63DOI: (10.1046/j.1469-0691.2000.00027.x) Copyright © 2000 European Society of Clinical Infectious Diseases Terms and Conditions

Figure 3 Protocol for testing susceptibility of Streptococcus pneumoniae. Clinical Microbiology and Infection 2000 6, 59-63DOI: (10.1046/j.1469-0691.2000.00027.x) Copyright © 2000 European Society of Clinical Infectious Diseases Terms and Conditions